✦ LIBER ✦

Phase study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer

✍ Scribed by Buter, Jan; Janssen, Richard A.J; Martens, Alexander; Sleijfer, Dirk Th; de Leij, Lou; Mulder, Nanno H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of low dose cyclophospham

✍ Walter D. Y. Quan; Grace E. Dean; Gary Lieskovsky; Malcolm S. Mitchell; Raymond 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 384 KB

Low-dose recombinant interleukin-2 and l

✍ Darcy V. Spicer; Ann Kelley; Robin Herman; Grace Dean; Lucy Stevenson; Malcolm S 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 331 KB

A phase II trial of low-dose total body

✍ Akmal Safwat; Henrik Schmidt; Lars Bastholt; Kirsten Fode; Susanne Larsen; Ninna 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Metastatic renal cell cancer treated wit

✍ Stoter, G.; Fosså, S.D.; Rugarli, C.; Symann, M.; Jasmin, C.; Israel, L.; Bijman 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Subcutaneous low-dose recombinant interl

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

A phase II study of interferon α and low

✍ A. Piga; Paolo Giordani; Agata Quattrone; Marco Giulioni; Giorgio De Signoribus; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 72 KB